SuperGen to Present at the Lazard Capital Markets Fifth Annual Healthcare Conference on November 18, 2008
November 13 2008 - 2:23PM
PR Newswire (US)
DUBLIN, Calif., Nov. 13 /PRNewswire-FirstCall/ -- SuperGen, Inc.
(NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery
and development of novel cancer therapies, today announced that
James S. Manuso, Ph.D., President and Chief Executive Officer is
scheduled to present at the Lazard Capital Markets Fifth Annual
Healthcare Conference on Tuesday, November 18, 2008 at the St.
Regis in New York, New York. SuperGen's presentation at the Lazard
Capital Markets Fifth Annual Healthcare Conference is scheduled to
begin at 4:40 p.m. EDT (1:40 p.m. PDT). A live webcast of the
presentation will be available on the investor relations section of
the Company's Web site at http://www.supergen.com/. The webcast
will be archived for 90 days. About SuperGen Based in Dublin,
Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the
discovery and development of novel cancer therapies. SuperGen is
developing a number of therapeutic anticancer products focused on
kinase and cell signaling inhibitors and DNA methyltransferase
inhibitors. For more information about SuperGen, please visit
http://www.supergen.com/. Contacts: SuperGen, Inc. Dorland Global
Public Relations Timothy L. Enns Michael Beckerich (Media) SVP,
Corporate Communications Tel: (212) 677-7632 & Business
Development Tel: (925) 560-2810 Email: DATASOURCE: SuperGen, Inc.
CONTACT: Timothy L. Enns, SVP, Corporate Communications &
Business Development of SuperGen, Inc., +1-925-560-2810, ; or
Media, Michael Beckerich of Dorland Global Public Relations,
+1-212-677-7632, , for SuperGen, Inc. Web site:
http://www.supergen.com/
Copyright
Supergen, Inc. (MM) (NASDAQ:SUPG)
Historical Stock Chart
From Sep 2024 to Oct 2024
Supergen, Inc. (MM) (NASDAQ:SUPG)
Historical Stock Chart
From Oct 2023 to Oct 2024